🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Poland / NCT06371352
Recruiting Not applicable

Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression

NCT06371352 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2024-05-15
Last updated
2024-10-15

Condition(s) studied

Unipolar DepressionBipolar Disorder

Investigational drug(s) / intervention(s)

iTBScTBSSham

iTBS: Active iTBS over the left DLPFC to induce the long term potentiation of stimulated area.

cTBS: Active cTBS over the right DLPFC to induce the long term potentiation of stimulated area.

Sham: Sham iTBS or cTBS over the left or right DLPFC respectively for placebo.

Study summary

Intermittent and continuous theta-burst stimulation (iTBS and cTBS respectively) are the newer modalities of transcranial magnetic stimulation with documented efficacy in treatment of depressed mood but with conflicting results regarding their efficacy in treatment of other symptoms of depression such as insomnia, daytime sleepiness and fatigue. This study will investigate the efficacy of iTBS over the left dorsolateral prefrontal cortex (DLPFC) and cTBS over the right DLPFC, compared to sham stimulation, in treatment of insomnia, daytime sleepiness and fatigue in depression.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * severe or moderate depressive episode (according to international classification of diseases (ICD)-10) without psychotic symptoms at the time of inclusion * Diagnosis of major depression (F33.1 or F33.2) or bipolar disorder (F31.3 or F31.4). * The score of the Athens Insomnia Scale five or more * Unchanged antidepressive pharmacotherapy at least one month prior to inclusion Exclusion Criteria: * Contraindications to transcranial magnetic stimulation, including ferromagnetic elements in head, pregnancy and epilepsy * Psychotic symptoms at the time of inclusion * Suicidal ideations and/or attempts within three months prior to inclusion

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institute of Psychiatry and Neurology Warsaw Poland Recruiting

More Jakub Antczak trials in Poland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06371352 on ClinicalTrials.gov ↗ ← All trials in Poland